Serrated polyps of right colon: Guilty or innocent?

Annals of Gastroenterology

Volumn 26, Issue 3, 2013, Pages 212-219

  Michalopoulos, George ^a   Tzathas, Charalampos ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Colorectal cancer; Serrated polyps; Sessile serrated polyps; Surveillance; Traditional serrated adenoma

Indexed keywords

APN GENE; BRAF GENE; CANCER LOCALIZATION; CHROMOENDOSCOPY; CHROMOSOMAL INSTABILITY; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYP; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; CTNNB1 GENE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SURVEILLANCE; ENDOSCOPY; ENTERITIS; GENE; GENE MUTATION; HUMAN; HYPERPLASTIC POLYP; MICROSATELLITE INSTABILITY; MMR GENE; NARROW BAND IMAGING; ONCOGENE K RAS; POLYPECTOMY; PREVALENCE; RECTUM ADENOMA; REVIEW; RISK FACTOR; SERRATED COLON POLYP; SEX DIFFERENCE; TRADITIONAL SERRATED ADENOMA; ULCERATIVE COLITIS; WNT SIGNALING PATHWAY;

EID: 84879429685     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990;14:524-537.
2. Grady WM. Genomic Instability and Colon Cancer. Cancer Metastasis Rev 2004;23:11-27.
3. Warthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev 2010;31:31-38.
4. Fu X, Li L, Peng Y. Wnt signalling in the serrated neoplastic pathway of colorectum: possible roles and epigenetic regulatory mechanisms. J Clin Pathol 2012;65:675-679.
5. Snover D, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated ("hyperplastic") polyposis. In: Bozman FT, Carneiro F, Hruban RH, et al, WHO Classification of Tumours Pathology and genetics Tumours of the digestive system, 4th edn. Berlin: Springer-Verlag, 2010.
6. Church JM. Clinical significance of small colorectal polyps. Dis Colon Rectum 2004;47:481-485.
7. Waye JD, Bilotta JJ. Rectal hyperplastic polyps: now you see them, now you don't-a differential point. Am J Gastroenterol 1990;85:1557-1559.
8. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-1329.
9. Huang CS, Farraye FA, Yang S, O'Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol 2011;106:229-240.
10. Torlakovic EE, Gomez JD, Driman DK, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008;32:21-29.
11. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30:1491-1501.
12. Yachida S, Mudali S, Martin SA, et al. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol 2009;33:1823-1832.
13. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 2004;28:1452-1459.
14. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology 2006;49:121-131.
15. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007;36:947-968.
16. Li L, Fu X, Zhang W, et al. Wnt signaling pathway is activated in right colon serrated polyps correlating to specific molecular form of β-catenin. Hum Pathol 2013;44:1079-1088.
17. Fukuyama R, Niculaita R, Peng K, et al. Mutated in Colorectal Cancer, a putative tumor supressor for serrated colorectal cancer, selectively represses β-catenin dependent transcription. Oncogene 2008;27:6044-6055.
18. Clark JC, Collan Y, Eide TJ, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985;36:179-186.
19. Correa P, Strong JP, Reif A, et al. Epidemiology of colorectal polypsprevalence in New Orleans and international comparisons. Cancer 1977;39:2258-2264.
20. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 1978;42:2839-2848.
21. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 1992;33:1508-1514.
22. Johannsen LG, Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol 1989;24:799-806.
23. Stemmermann GN, Yatani R. Diverticulosis and polyps of the large intestine. A necropsy study of Hawaii Japanese. Cancer 1973;31:1260-1270.
24. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-825.
25. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-842.
26. Zois C, Christodoulou D, Katsanos K, et al. Endoscopic resection and histological evaluation of colorectal polyps: Is it a definitive treatment? Ann Gastroenterol 2011;24:115-120.
27. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-1407.
28. Sumner HW, Wasserman NF, McClain CJ. Giant hyperplastic polyposis of the colon. Dig Dis Sci 1981;26:85-89.
29. Cooper HS, Patchefsky AS, Marks G. Adenomatous and carcinomatous changes within hyperplastic colonic epithelium. Dis Colon Rectum 1979;22:152-156.
30. Urbanski SJ, Kossakowska AE, Marcon N, et al. Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol 1984;8:551-556.
31. Franzin G, Zamboni G, Scarpa A, et al. Hyperplastic (metaplastic) polyps of the colon: a histologic and histochemical study. Am J Surg Pathol 1984;8:687-698.
32. Jass JR. Metaplastic polyps and polyposis of the colorectum. Histopathology 1980;4:579.
33. Jass JR. Relation between metaplastic polyp and carcinoma of the colorectum. Lancet 1983;1:28-30.
34. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-755.
35. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
36. Brenner H, Hoffmeister M, Arndt V, et al. Protection from right-and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010;102:89-95.
37. Jover R, Nguyen T-P, Perez-Carbonell L, et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology 2011;140:1174-1181.
38. Hetzel J, Huang CS, Coukos JA, et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 2010;105:2656-2664.
39. Kahi CJ, Hewett DG, Norton DL, et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011;9:42-46.
40. Guarinos C, Sanchez-Fortun C, Rodriguez-Soler M, Alenda C, Paya A, Jover R. Serrated polyposis syndrome: Molecular, pathological and clinical aspects. World J Gastroenterol 2012;18:2452-2461.
41. Lieberman AD, Rex KD, Winawer JS, Giardiello MF, Johnson AD, Levin RT. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US multi-society task force on colorectal cancer. Gastroenterology 2012;143:844-857.
42. Van Assche G, Dingnass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1-33.
43. Matkowsky K, Chen Z, Rao S, Yang G. Dysplastic lesions in inflammatory bowel disease. Molecular pathogenesis to morphology. Arch Pathol Lab Med 2013;137:338-350.
44. Bossard C, Denis M, Bezieau S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 2007;18:1093-1097.
45. Paskett ED, Reeves KW, Pineau B, et al. The association between cigarette smoking and colorectal polyp recurrence (United States). Cancer Causes Control 2005;16:1021-1033.
46. Shrubsole MJ, Wu H, Ness RM, et al. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 2008;167:1050-1058.
47. Wallace K, Grau MV, Ahnen D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2009;18:2310-2317.
48. Dale C. Snover MD. Update on the serrated pathway to colorectal carcinoma. Hum Pathol 2011;42:1-10.
49. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 2010;59:1094-1100.
50. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;13:30-39.
51. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779-1784.
52. Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006;38:266-270.
53. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first degree relatives of patients with hyperplastic polyposis syndrome. Gut 2010;59:1222-1225.
54. Carvajal-Carmona LG, Howarth KM, Lockett M, et al. Molecular classifi-cation and genetic pathways in hyperplastic polyposis syndrome. J Pathol 2007;212:378-385.
55. Kalady MF, Jarrar A, Leach B, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011;54:164-170.
56. Boparai KS, van den Broek FJC, van Eeden S, Fockens P, Dekker E. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy 2011;43:676-682.
57. Edelstein DL, Axilbund JE, Hylid LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut 2012;62:404-408.
58. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyp and serrated adenomas of colon: classification, molecular genetics, natural history and clinical management. Gastroenterol Clin North Am 2008;37:25-46.
59. Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54:906-909.
60. Patai A, Molnar B, Tulassay Z, Sipos F. Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol 2013;19:607-615.
61. Endo A, Koizumi H, Takahashi M, et al. A significant imbalance in mitosis versus apoptosis accelerates the growth rate of sessile serrated adenoma/polyp. Virchows Arch 2013;462:131-139.
62. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010;63:681-686.
63. Tholoor S, Tsagkournis O, Basford P, Bandari P. Managing difficult polyps: techniques and pitfalls. Ann Gastroenterol 2013;26:114-121.
64. Atkin WS, Valori R, Kuipers EJ, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition. Colonoscopic surveillance following adenoma removal. Endoscopy 2012;44:SE151-SE163.
65. Burnett H, Newcomb P, Veenstra D. The impact of colonoscopy screening guidelines that incorporate precursors in the serrated pathway: A cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev 2013;22:477-478.